ROYAL BANK OF CANADA - DURATA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of DURATA THERAPEUTICS INC
ValueSharesWeighting
Q3 2014$917,000
-7.9%
72,294
+23.6%
0.00%0.0%
Q2 2014$996,000
+38.3%
58,500
+9.4%
0.00%0.0%
Q1 2014$720,000
-0.7%
53,450
-5.7%
0.00%0.0%
Q4 2013$725,000
+70.2%
56,700
+20.3%
0.00%
Q3 2013$426,000
+63.8%
47,137
+30.5%
0.00%
Q2 2013$260,00036,1170.00%
Other shareholders
DURATA THERAPEUTICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 508,472$4,596,0003.19%
Broadfin Capital, LLC 383,227$3,464,0000.62%
Orbimed Advisors 1,785,714$16,143,0000.29%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 275,979$2,495,0000.12%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 1,188,571$10,745,0000.10%
Lenox Wealth Advisors, LLC 8,000$72,0000.07%
STONERIDGE INVESTMENT PARTNERS LLC 30,732$278,0000.06%
Loeb Offshore Management LP 19,621$177,0000.06%
Alyeska Investment Group, L.P. 100,000$904,0000.04%
PARADIGM ASSET MANAGEMENT CO LLC 25,000$226,000,0000.04%
View complete list of DURATA THERAPEUTICS INC shareholders